Ham Zand & Dr. Marco Zahedi discuss the utility, value and limitations of serology based COVID-19 screening. Testing is a critical component of the battle against the pandemic, yet the availability of tests is limited. This is a rapidly evolving situation and this episode provides insight into tests that are not FDA approved but are currently available for COVID-19 antibody testing.